miR-651-3p Enhances the Sensitivity of Hepatocellular Carcinoma to Cisplatin via Targeting ATG3-Mediated Cell Autophagy

<div>ATG3 was a downstream target of miR-651-3p and was significantly upregulated in tumor tissues. (a) The binding sites of miR-651-3p and ATG3. (b) The binding effect of miR-651-3p and ATG3 observed by dual-luciferase reporter assay. (c) The mRNAs level of miR-651-3p significantly upregulated in tumor tissues.</div>

Journal of Oncology

fig3

Figure 3

Figure 3: miR-651-3p Enhances the Sensitivity of Hepatocellular Carcinoma to Cisplatin via Targeting ATG3-Mediated Cell Autophagy 